Skip to content
No results
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact

Hello, feel free to inquire - up to 50% OFF!

dengyuemed logo
China Medicine Wholesaler
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
dengyuemed logo
China Medicine Wholesaler
generic upadacitinib approved in china marking the start of jak inhibitor competition
News

Generic Upadacitinib Approved in China, Marking the Start of JAK Inhibitor Competition

DengYueMed, DengYue 28/04/2026
belantamab mafodotin approved in china for multiple myeloma first-in-class bcma adc marks new milestone
News

Belantamab Mafodotin Approved in China for Multiple Myeloma: First-in-Class BCMA ADC Marks New Milestone

DengYueMed, DengYue 21/04/2026
sevabertinib approved in china for her2-mutant nsclc a new oral targeted therapy option
News

Sevabertinib Approved in China for HER2-Mutant NSCLC: A New Oral Targeted Therapy Option

DengYueMed, DengYue 16/04/2026
nmpa approves gsk depemokimab in china for severe eosinophilic asthma with twice-yearly dosing
News

NMPA Approves GSK Depemokimab in China for Severe Eosinophilic Asthma with Twice-Yearly Dosing

DengYueMed, DengYue 31/03/2026
ABSK061 achondroplasia orphan drug designation
News

ABSK061 Achondroplasia Orphan Drug Designation: Abbisko Therapeutics Advances Targeted Therapy

DengYueMed, DengYue 20/03/2026
11 new cancer drugs approved
News

11 New Cancer Drugs Approved: Breakthroughs in Lung Cancer, Breast Cancer and Prostate Cancer Treatment

DengYueMed, DengYue 06/03/2026
NMPA Approved Drugs List – February 2026
News

NMPA Approved Drugs List – February 2026: 3 Innovative Drugs Approved in China

DengYueMed, DengYue 05/03/2026
what is qipani olaparib used for china approves first domestic olaparib generic, marking a new milestone in parp inhibitor access
News

What Is Qipani Olaparib Used For? China Approves First Domestic Olaparib Generic, Marking a New Milestone in PARP Inhibitor Access

Dengyue 16/02/2026
adebrelimab approval in China the first domestic PD-L1 antibody for small cell lung cancer
News

Adebrelimab Approval in China: The First Domestic PD-L1 Antibody for Small Cell Lung Cancer

Dengyue 10/02/2026
the role of pharmaceutical wholesalers in 2026 from channel to strategic partner aligning with drugmakers’ 6 priorities
News

The Role of Pharmaceutical Wholesalers in 2026: From Channel to Strategic Partner Aligning with Drugmakers’ 6 Priorities

Dengyue 23/01/2026
the different forms of navelbine—from classic chemotherapy to a flexible multi-formulation therapy
News

The Different Forms of Navelbine—From Classic Chemotherapy to a Flexible Multi-Formulation Therapy

Dengyue 21/01/2026
tpiao approved for a new indication clinical progress of recombinant human thrombopoietin in the treatment of thrombocytopenia
News

TPIAO Approved for a New Indication: Clinical Progress of Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia

Dengyue 09/01/2026
Quick Links
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
Get In Touch
  • Phone: +852-56986617
  • Whats APP: +852-56986617
  • Fax: +852-56986617
  • Email: inquiry@dengyuemed.com
  • Address: 6/F, Tai Tak Industrial Building, New Territories, Hong Kong
X-twitter Facebook Youtube Linkedin Instagram

Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights

WhatsApp us